Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mitsubishi UFJ Financial Group Inc. Common Stock (MUFG) vs Novavax Inc (NVAX) Price & Performance

Mitsubishi UFJ Financial Group Inc. Common StockTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Mitsubishi UFJ Financial Group Inc. Common Stock vs Novavax Inc — how do they compare? Mitsubishi UFJ Financial Group Inc. Common Stock trades at $22.38 (market cap $249.48B), while Novavax Inc trades at $12.75 (market cap $1.82B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 137.1× Novavax Inc's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.4% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mitsubishi UFJ Financial Group Inc. Common Stock for 0 Days and Novavax Inc for 59 Days on average.

MUFGNVAX
Market Cap
$249.48B$1.82B
Volume
4,008,1606,198,505
Sector
FinancialsHealth
52-Week High
$24.13$12.56
52-Week Low
$14.62$6.22
Typical Hold Time
0 Days59 Days
Enterprise Value
$28.96T$1.39B
Dividend Yield
2.4%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mitsubishi UFJ Financial Group Inc. Common Stock

No Aura AI signal available yet.

Novavax Inc

Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and strong analyst support (73.9% buy ratings). The company reported revenue of $1.12B in 2025 with a net income of $440.3M, marking a significant turnaround from prior losses, though 2026 projections show a return to negative net income. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.

The outlook is mixed: strong valuation ratios (P/E of 3.14, EV/EBITDA of 1.72) and recent earnings beats suggest undervaluation, but persistent cash burn and negative equity pose risks. Investment opportunity lies in partnership-driven growth, while risks include execution challenges and reliance on vaccine demand. Wall Street sentiment remains optimistic despite fundamental volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MUFG
93% Buy7% Sell
Avg holding period · 0 Days
NVAX
55% Buy45% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About Mitsubishi UFJ Financial Group Inc. Common Stock

Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.

Read more on MUFG →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX →